Evidence map›Paper›PMID 31095959›Full record

ArticleJournal of pharmaceutical sciences2020

Nanobubbles in Reconstituted Lyophilized Formulations: Interaction With Proteins and Mechanism of Formation.

Jared R Snell, N S Krishna Kumar, Raj Suryanarayanan, Theodore W Randolph

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jared R SnellDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80309.
N S Krishna KumarDepartment of Pharmaceutics, University of Minnesota, Minneapolis, Minnesota 55455.
Raj SuryanarayananDepartment of Pharmaceutics, University of Minnesota, Minneapolis, Minnesota 55455.
Theodore W RandolphDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80309. Electronic address: theodore.randolph@colorado.edu.
University of Colorado Boulder · USUniversity of Minnesota · US

Funding

Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic ProteinsR01EB006006 · NIBIB · UNIVERSITY OF COLORADO · PI RANDOLPH, THEODORE W · 2006 to 2017
$7.2M
Effect of Container Surface Structure on Cavitation-Induced Protein Particulate FormationR21EB026006 · NIBIB · UNIVERSITY OF COLORADO · PI GOODWIN, ANDREW P, RANDOLPH, THEODORE W · 2018 to 2019
$524k
NIBIB NIH HHS R01 EB006006NIBIB NIH HHS R21 EB026006
6 · The paper itself

Abstract

Reconstitution of lyophilized disaccharide formulations results in the formation of nanosized air bubbles that persist in suspension for weeks. If proteins are present, interactions with nanobubbles may cause loss of monomeric protein and formation of subvisible particles. The goals of this work are to determine the mechanism(s) by which nanobubbles form in reconstituted lyophilized formulations and to develop strategies for reducing nanobubble generation. We hypothesize that nanobubbles are created from nanosized gas pockets within lyophilized solids, which become bubbles when the surrounding matrix is dissolved away during reconstitution. Nanosized voids may originate from small ice crystals formed within the concentrated liquid during freezing that subsequently sublime during drying. Nanobubble concentrations are correlated with the extent of mannitol crystallization during freezing. Nanosized ice crystals, induced by the release of water during mannitol crystallization, were responsible for nanobubble formation. The presence of trehalose or sucrose, in formulations with low mannitol concentrations, inhibited excipient crystallization during lyophilization and reduced nanobubble levels following reconstitution. Our results show a correlation between nanobubble formation and concentrations of insoluble IL-1ra aggregates, suggesting that minimizing nanobubble generation may be an effective strategy for reducing protein aggregation following reconstitution.

Indexed as

CrystallizationDrug CompoundingDrug StabilityFreeze DryingHumansInterleukin 1 Receptor Antagonist ProteinMannitolNanoparticlesParticle SizeProtein AggregatesRecombinant ProteinsSucroseTrehaloseInterleukin 1 Receptor Antagonist ProteinMannitolProtein AggregatesRecombinant ProteinsSucroseTrehalosecrystallizationLyophilizationnanoparticle(s)protein aggregationtrehalose

Identifiers

PMID31095959
PMCPMC6851470
OpenAlexW2945431610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.